Report of the Paris Consensus Meeting on Expanded Criteria Donors in Liver Transplantation

被引:238
作者
Durand, Franois
Renz, John F. [2 ]
Alkofer, Barbara [1 ]
Burra, Patrizia [3 ]
Clavien, Pierre Alain [4 ]
Porte, Robert J. [5 ]
Freeman, Richard B. [6 ]
Belghiti, Jacques [1 ]
机构
[1] Univ Paris 07, Hosp Beaujon, F-92110 Clichy, France
[2] New York Presbyterian Hosp, Ctr Liver Dis & Transplantat, New York, NY USA
[3] Univ Padua, Dept Surg & Gastroenterol Sci, Gastroenterol Sect, Padua, Italy
[4] Univ Zurich Hosp, Dept Visceral & Transplantat Surg, Swiss Hepatopancreaticobiliary Ctr, CH-8091 Zurich, Switzerland
[5] Univ Groningen, Univ Med Ctr Groningen, Dept Surg Hepatobiliary Surg & Liver Transplantat, Groningen, Netherlands
[6] Tufts Univ New England Med Ctr, Div Transplantat, Boston, MA USA
关键词
D O I
10.1002/lt.21668
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Because of organ shortage and a constant imbalance between available organs and candidates for liver transplantation, expanded criteria donors are needed. Experience shows that there are wide variations in the definitions, selection criteria, and use of expanded criteria donors according to different geographic areas and different centers. Overall, selection criteria for donors have tended to be relaxed in recent years. Consensus recommendations are needed. This article reports the conclusions of a consensus meeting held in Paris in March 2007 with the contribution of experts from Europe, the United States, and Asia. Definitions of expanded criteria donors with respect to donor variables (including age, liver function tests, steatosis, infections, malignancies, and heart-beating versus non-heart-beating, among others) are proposed. It is emphasized that donor quality represents a continuum of risk rather than "good or bad." A distinction is made between donor factors that generate increased risk of graft failure and factors independent of graft function, such as transmissible infectious disease or donor-derived malignancy, that may preclude a good outcome. Updated data concerning the risks associated with different donor variables in different recipient populations are given. Recommendations on how to safely expand donor selection criteria are proposed. Liver Transpl. 14:1694-1707, 2008. (C) 2008 AASLD.
引用
收藏
页码:1694 / 1707
页数:14
相关论文
共 120 条
[1]   Survival following liver transplantation from non-heart-beating donors [J].
Abt, PL ;
Desai, NM ;
Crawford, MD ;
Forman, LM ;
Markmann, JW ;
Olthoff, KM ;
Markmann, JF .
ANNALS OF SURGERY, 2004, 239 (01) :87-92
[2]   Normalised intrinsic mortality risk in liver transplantation: European Liver Transplant Registry study [J].
Adam, R ;
Cailliez, V ;
Majno, P ;
Karam, V ;
McMaster, P ;
Calne, RY ;
O'Grady, J ;
Pichlmayr, R ;
Neuhaus, P ;
Otte, JB ;
Hoeckerstedt, K ;
Bismuth, H .
LANCET, 2000, 356 (9230) :621-627
[3]   Extended-donor criteria liver allografts [J].
Alkofer, Barbara ;
Samstein, Benjamin ;
Guarrera, James V. ;
Kin, Cindy ;
Jan, Dominique ;
Bellemare, Sarah ;
Kinkhabwala, Milan ;
Brown, Robert, Jr. ;
Emond, Jean C. ;
Renz, John F. .
SEMINARS IN LIVER DISEASE, 2006, 26 (03) :221-233
[4]   The use of hepatitis C-infected grafts in liver transplantation [J].
Arenas, JI ;
Vargas, HE ;
Rakela, J .
LIVER TRANSPLANTATION, 2003, 9 (11) :S48-S51
[5]   Waitlist mortality decreases with increased use of extended criteria donor liver grafts at adult liver transplant centers [J].
Barshes, N. R. ;
Horwitz, I. B. ;
Franzini, L. ;
Vierling, J. M. ;
Goss, J. A. .
AMERICAN JOURNAL OF TRANSPLANTATION, 2007, 7 (05) :1265-1270
[6]   TRANSPLANTATION FOR FULMINANT AND SUBFULMINANT HEPATIC-FAILURE WITH PRESERVATION OF PORTAL AND CAVAL FLOW [J].
BELGHITI, J ;
NOUN, R ;
SAUVANET, A ;
DURAND, F ;
ASCHEHOUG, J ;
ERLINGER, S ;
BENHAMOU, JP ;
BERNUAU, J .
BRITISH JOURNAL OF SURGERY, 1995, 82 (07) :986-989
[7]  
Belzer F O, 1986, Prog Clin Biol Res, V224, P291
[8]   THE USE OF UW-SOLUTION IN CLINICAL TRANSPLANTATION - A 4-YEAR EXPERIENCE [J].
BELZER, FO ;
DALESSANDRO, AM ;
HOFFMANN, RM ;
KNECHTLE, SJ ;
REED, A ;
PIRSCH, JD ;
KALAYOGLU, M ;
SOLLINGER, HW ;
BUSUTTIL, RW ;
DIETHELM, G .
ANNALS OF SURGERY, 1992, 215 (06) :579-585
[9]   Addition of adenosine monophosphate-activated protein kinase activators to University of Wisconsin solution:: A way of protecting rat steatotic livers [J].
Ben Mosbah, Ismail ;
Massip-Salcedo, Marto ;
Fernández-Monteiro, Izabel ;
Xaus, Carme ;
Bartrons, Ramon ;
Boillot, Olivier ;
Rosello-Catafau, Joan ;
Peralta, Carmen .
LIVER TRANSPLANTATION, 2007, 13 (03) :410-425
[10]   Preservation of steatotic livers in IGL-1 solution [J].
Ben Mosbah, Ismail ;
Rosello-Catafau, Joan ;
Franco-Gou, Rosa ;
Ben Abdennebi, Hassen ;
Saidane, Dalila ;
Ramella-Virieux, Silvina ;
Boillot, Olivier ;
Peralta, Carmen .
LIVER TRANSPLANTATION, 2006, 12 (08) :1215-1223